The soluble biomarker calprotectin (an S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab.
about
Identification of S100A9 as biomarker of responsiveness to the methotrexate/etanercept combination in rheumatoid arthritis using a proteomic approachThe predictive value of serum S100A9 and response to etanercept is not confirmed in a large UK rheumatoid arthritis cohort.The neutrophil protein S100A12 is associated with a comprehensive ultrasonographic synovitis score in a longitudinal study of patients with rheumatoid arthritis treated with adalimumab.Response to Infliximab in Crohn's Disease: Genetic Analysis Supporting Expression Profile.Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis.Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical RemissionCalprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity.Calprotectin (S100A8/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis.Genetics and the impact on treatment protocols in patients with rheumatoid arthritis.S100A8/A9 as a biomarker for synovial inflammation and joint damage in patients with rheumatoid arthritis.Calprotectin levels in patients with rheumatoid arthritis to assess and association with exercise treatment.Genetic and genomic markers of anti-TNF treatment response in rheumatoid arthritis.Association of Serum Calprotectin (S100A8/A9) Level With Disease Relapse in Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.The danger from within: alarmins in arthritis.Calprotectin in rheumatic diseases.Spatiotemporal expression of endogenous TLR4 ligands leads to inflammation and bone erosion in mouse collagen-induced arthritis.Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study.Calprotectin (S100A8/A9) should preferably be measured in EDTA-plasma; results from a longitudinal study of patients with rheumatoid arthritis.Calprotectin in patients with chronic rheumatoid arthritis correlates with disease activity and responsiveness to methotrexate.Serum Calprotectin Versus Acute-Phase Reactants in the Discrimination of Inflammatory Disease Activity in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors.Calprotectin in rheumatoid arthritis : association with disease activity in a cross-sectional and a longitudinal cohort.Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis.
P2860
Q28542901-DE3FFA05-8BED-4442-A682-35EDA942CBABQ33731299-9143BEDF-13A6-4045-AFA6-FC0F60935899Q34333827-308AC606-72E4-4AE6-A8D3-E6B58263E518Q35963141-CC88FFF4-859C-45A9-8AFB-2B9BBD268F92Q36067062-1CF67CE0-C4E6-44BC-99E7-71EE886A3101Q36188496-4F3CA8B4-668A-4B9A-9615-4CE4390E6B41Q37080199-23FE4AF6-5312-4287-BC85-9A0E48CE1D9FQ37584844-F9C35D4C-5F32-464C-B956-8C36FCC81FA6Q38044756-D89FC118-816E-4991-8275-CD4DA48AC21FQ38191587-98425321-7A14-4AB0-B840-05BFF97B4B78Q38393444-55C4884A-742A-4DF5-80A5-85B021DF7CCCQ38529234-6D493753-907E-42BF-BD23-47D60E146EEDQ38840696-E90756A9-200E-40E0-A76D-56B3A987BA41Q38979165-30DBDFEC-F327-4FBE-A62C-D5BB8D082B28Q39022858-31A1D262-0FF3-46C5-808A-3F2A0B6876BCQ39503170-85446C45-900E-4394-8CAA-DB4843496D2EQ41497288-523D4E29-D81A-4B16-8319-2CB4A9F6EC50Q47253535-2A4AA7F6-E0B1-43B8-B1E0-0BE57CAFA27DQ47306233-1DE44FE2-6253-4567-ADA8-1ECEDE017890Q48247861-0C202C90-1D85-44CF-B920-B69AB112AB84Q50879100-0735CDB4-E91B-496C-8A4D-511580B8FDE2Q53212565-8E5CD3EC-1562-47C0-A82E-48A4635C7BD5Q54501729-A2206711-C56A-46D1-B760-EC7FF273A595
P2860
The soluble biomarker calprotectin (an S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The soluble biomarker calprote ...... ritis treated with adalimumab.
@ast
The soluble biomarker calprote ...... ritis treated with adalimumab.
@en
type
label
The soluble biomarker calprote ...... ritis treated with adalimumab.
@ast
The soluble biomarker calprote ...... ritis treated with adalimumab.
@en
prefLabel
The soluble biomarker calprote ...... ritis treated with adalimumab.
@ast
The soluble biomarker calprote ...... ritis treated with adalimumab.
@en
P2093
P2860
P356
P1476
The soluble biomarker calprote ...... ritis treated with adalimumab.
@en
P2093
Hilde Berner Hammer
Magne K Fagerhol
Tale Norbye Wien
P2860
P2888
P356
10.1186/AR3503
P577
2011-10-26T00:00:00Z